Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
<p>Abstract</p> <p>Background</p> <p>A novel tyrosine kinase receptor EphA2 is expressed at high levels in advanced and metastatic cancers. We examined whether vaccinations with synthetic mouse EphA2 (mEphA2)-derived peptides that serve as T cell epitopes could induce protective and therapeutic anti...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2004-11-01
|
| Serija: | Journal of Translational Medicine |
| Teme: | |
| Online pristup: | http://www.translational-medicine.com/content/2/1/40 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|